Growth response of syndromic versus non-syndromic children born small for  gestational age (SGA) to growth hormone therapy: a Belgian study.

Becker, Marianne; Thomas, Muriel; Brachet, Cécile; Heinrichs, Claudine; Dotremont, Hilde; De Schepper, Jean; Lysy, Philippe; Beckers, Dominique; BESPEED, group

doi:10.3389/fendo.2023.1112938

Article (Scientific journals)

Growth response of syndromic versus non-syndromic children born small for gestational age (SGA) to growth hormone therapy: a Belgian study.

Becker, Marianne; Thomas, Muriel; Brachet, Cécile et al.

2023 • In Frontiers in Endocrinology, 14, p. 1112938

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/311585

DOI
10.3389/fendo.2023.1112938

PubMed
37334282

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Growth response of syndromic versus non-syndromic children born small for gestational age (SGA) to growth hormone therapy_A belgian study.pdf

Author postprint (704.83 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Growth Hormone; Human Growth Hormone; Recombinant Proteins; Infant, Newborn; Female; Adult; Humans; Child; Human Growth Hormone/therapeutic use; Belgium/epidemiology; Gestational Age; Fetal Growth Retardation/drug therapy; Infant, Newborn, Diseases/drug therapy; adult height; children; growth; growth hormone; short for gestational age; short stature; syndromic

Abstract :

[en] INTRODUCTION: A substantial proportion of SGA patients present with a syndrome underlying their growth restriction. Most SGA cohorts comprise both syndromic and non-syndromic patients impeding delineation of the recombinant human growth hormone (rhGH) response. We present a detailed characterization of a SGA cohort and analyze rhGH response based on adult height (AH). METHODS: Clinical and auxological data of SGA patients treated with rhGH, who had reached AH, were retrieved from BELGROW, a national database of all rhGH treated patients held by BESPEED (BElgian Society for PEdiatric Endocrinology and Diabetology). SGA patients were categorized in syndromic or non-syndromic patients. RESULTS: 272 patients were included, 42 classified as syndromic (most frequent diagnosis (n=6): fetal alcohol syndrome and Silver-Russell syndrome). Compared with non-syndromic patients, syndromic were younger [years (median (P10/P90)] 7.43 (4.3/12.37) vs 10.21 (5.43/14.03), p=0.0005), shorter (height SDS -3.39 (-5.6/-2.62) vs -3.07 (-3.74/-2.62), p=0.0253) and thinner (BMI -1.70 (-3.67/0.04) vs -1.14 (-2.47/0.27) SDS, p=0.0054) at start of rhGH treatment. First year rhGH response was comparable (delta height SDS +0.54 (0.24/0.94) vs +0.56 (0.26/0.92), p=0.94). Growth pattern differed with syndromic patients having a higher prepubertal (SDS +1.26 vs +0.83, p=0.0048), but a lower pubertal height gain compared to the non-syndromic group (SDS -0.28 vs 0.44, p=0.0001). Mean rhGH dose was higher in syndromic SGA patients (mg/kg body weight/day 0.047 (0.039/0.064) vs 0.043 (0.035/0.056), p=0.0042). AH SDS was lower in syndromic SGA patients (-2.59 (-4.99/-1.57) vs -2.32 (-3.3/-1.2), p=0.0107). The majority in both groups remained short (<-2 SDS: syndromic 71%, non-syndromic 63%). Total height gain was comparable in both groups (delta height SDS +0.76 (-0.70/1.48) vs +0.86 (-0.12/1.86), p=0.41). CONCLUSIONS: Compared to non-syndromic SGA patients, syndromic SGA patients were shorter when starting rhGH therapy, started rhGH therapy earlier, and received a higher dose of rhGH. At AH, syndromic SGA patients were shorter than non-syndromic ones, but their height gain under rhGH therapy was comparable.

Disciplines :

Endocrinology, metabolism & nutrition
Pediatrics

Author, co-author :

Becker, Marianne; Department of Pediatric Endocrinology and Diabetology, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.

Thomas, Muriel; The BElgian Society for PEdiatric Endocrinology and Diabetology (BESPEED), Brussels, Belgium.

Brachet, Cécile; Pediatric Endocrinology Unit, Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Université libre de Bruxelles (ULB), Brussels, Belgium.

Heinrichs, Claudine; Pediatric Endocrinology Unit, Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Université libre de Bruxelles (ULB), Brussels, Belgium.

Dotremont, Hilde; Department of Pediatric Endocrinology and Diabetology, University Hospital Antwerp, Edegem, Belgium.

De Schepper, Jean; University Hospital of Brussels, Brussels, Belgium.

Lysy, Philippe; Department of Pediatric Endocrinology and Diabetology, UCLouvain, Brussels, Belgium.

Beckers, Dominique; Department of Pediatric Endocrinology and Diabetology, UCLouvain, CHU UCL Namur, Yvoir, Belgium.

BESPEED, group

Other collaborator :

Rochtus, Anne

Parent, Anne-Simone ; Centre Hospitalier Universitaire de Liège - CHU > > Service de pédiatrie

Klink, Daniel

Massa, Guy

Logghe, Karl

De Waele, Kathleen

Casteels, Kristina

Cools, Martine

Staels, Willem

Language :

English

Title :

Growth response of syndromic versus non-syndromic children born small for gestational age (SGA) to growth hormone therapy: a Belgian study.

Publication date :

June 2023

Journal title :

Frontiers in Endocrinology

eISSN :

1664-2392

Publisher :

Frontiers Media S.A., Ch

Volume :

Pages :

1112938

Peer reviewed :

Peer Reviewed verified by ORBi

Commentary :

Available on ORBi :

since 19 January 2024

Statistics

Number of views

51 (2 by ULiège)

Number of downloads

36 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Karlberg J Albertsson-Wikland K. Growth in full- term small-for-Gestational-Age infants: From birth to final height. Pediatr Res (1995) 38(5):733–9. doi: 10.1203/00006450-199511000-00017
Hokken-Koelega ACS De Ridder M Lemmen RJ Hartog HD De Muinck Keizer-Schrama SMPF Drop SLS. Children born small for gestational age: Do they catch up? Pediatr Res (1995) 38(2):267–71. doi: 10.1203/00006450-199508000-00022
Leger J Limoni C Collin D Czernichow P. Prediction factors in the determination of final height in subjects born small for gestational age. Pediatr Res (1998) 43(6):808–12. doi: 10.1203/00006450-199806000-00015
Van Pareren Y Mulder P Houdijk M Jansen M Reeser M Hokken-Koelega A. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial. J Clin Endocrinol Metab (2003) 88(8):3584–90. doi: 10.1210/jc.2002-021172
Dahlgren J Wikland KA. Swedish Study group for growth hormone treatment. final height in short children born small for gestational age treated with growth hormone. Pediatr Res (2005) 57(2):216–22. doi: 10.1203/01.PDR.0000148716.71231.81
Carel JC Chatelain P Rochiccioli P Chaussain JL. Improvement in adult height after growth hormone treatment in adolescents with short stature born small for gestational age: Results of a randomized controlled study. J Clin Endocrinol Metab (2003) 88(4):1587–93. doi: 10.1210/jc.2002-021123
van Dijk M Bannink EMN van Pareren YK Mulder PGH Hokken-Koelega ACS. Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (SGA) and untreated short SGA controls. J Clin Endocrinol Metab (2007) 92(1):160–5. doi: 10.1210/jc.2006-1073
Ranke MB Lindberg A Cowell CT Wikland KA Reiter EO Wilton P et al. Prediction of response to growth hormone treatment in short children born small for gestational age: Analysis of data from KIGS (Pharmacia international growth database). J Clin Endocrinol Metab (2003) 88(1):125–31. doi: 10.1210/jc.2002-020867
Straetemans S Thomas M Craen M Rooman R De Schepper J. Poor growth response during the first year of growth hormone treatment in short prepubertal children with growth hormone deficiency and born small for gestational age: a comparison of different criteria. Int J Pediatr Endocrinol (2018). doi: 10.1186/s13633-018-0064-3
Saenger P Czernichow P Hughes I Reiter EO. Small for gestational age: short stature and beyond. Endocr Rev (2007) 28(2):219–51. doi: 10.1210/er.2006-0039
Beisti Ortego A Fuertes Rodrigo C Ferrer Lozano M Labarta Aizpun JI de Arriba Muñoz A. Adult height in short children born small for gestational age treated with growth hormone. Med Clin (Barc) (2020) 154(8):289–94. doi: 10.1016/j.medcli.2019.06.005
Adler E Lambert AS Bouvattier C Thomas-Teinturier C Rothenbuhler A de Boissieu P et al. Determinants of final height in patients born small for gestational age treated with recombinant growth hormone. Horm Res Paediatr (2021) 94(1–2):52–62. doi: 10.1159/000516557
Lem AJ van der Kaay DCM de Ridder MAJ Bakker-van Waarde WM van der Hulst FJPCM Mulder JC et al. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial. J Clin Endocrinol Metab (2012) 97(11):4096–105. doi: 10.1210/jc.2012-1987
Renes JS Willemsen RH Mulder JC Bakker-van Waarde WM Rotteveel J Oostdijk W et al. New insights into factors influencing adult height in short SGA children: Results of a large multicentre growth hormone trial. Clin Endocrinol (2015) 82(6):854–61. doi: 10.1111/cen.12677
Ranke MB Lindberg A Board on behalf of the KI. Height at start, first-year growth response and cause of shortness at birth are major determinants of adult height outcomes of short children born small for gestational age and silver-Russell syndrome treated with growth hormone: Analysis of data from KIGS. HRP (2010) 74(4):259–66. doi: 10.1159/000289570
Glińska M Walczak M Wikiera B Pyrżak B Majcher A Paluchowska M et al. Response to treatment with recombinant human growth hormone (rhGH) of short stature children born too small for gestational age (SGA) in selected centres in Poland. J Clin Med (2022) 30(11):3096. doi: 10.3390/jcm11113096
Toumba M Albanese A Azcona C Stanhope R. Effect of long-term growth hormone treatment on final height of children with Russell-silver syndrome. Horm Res Paediatr (2010) 74(3):212–7. doi: 10.1159/000295924
Binder G Liebl M Woelfle J Eggermann T Blumenstock G Schweizer R. Adult height and epigenotype in children with silver-Russell syndrome treated with GH. HRP (2013) 80(3):193–200. doi: 10.1159/000354658
Smeets CCJ Zandwijken GRJ Renes JS Hokken-Koelega ACS. Long-term results of GH treatment in silver-Russell syndrome (SRS): Do they benefit the same as non-SRS short-SGA? J Clin Endocrinol Metab (2016) 101(5):2105–12. doi: 10.1210/jc.2015-4273
Niklasson A Ericson A Fryer JG Karlberg J Lawrence C Karlberg P. An update of the Swedish reference standards for weight, length and head circumference at birth for given gestational age (1977-1981). Acta Paediatr Scand (1991) 80(8–9):756–62. doi: 10.1111/j.1651-2227.1991.tb11945.x
Villar J Cheikh Ismail L Victora CG Ohuma EO Bertino E Altman DG et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the newborn cross-sectional study of the INTERGROWTH-21st project. Lancet (2014) 384(9946):857–68. doi: 10.1016/S0140-6736(14)60932-6
Villar J Giuliani F Fenton TR Ohuma EO Ismail LC Kennedy SH et al. INTERGROWTH-21st very preterm size at birth reference charts. Lancet (2016) 387(10021):844–5. doi: 10.1016/S0140-6736(16)00384-6
Roelants M Hauspie R Hoppenbrouwers K. References for growth and pubertal development from birth to 21 years in Flanders, Belgium. Ann Hum Biol (2009) 36(6):680–94. doi: 10.3109/03014460903049074
Blethen SL Baptista J Kuntze J Foley T LaFranchi S Johanson A. Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. J Clin Endocrinol Metab (1997) 82(2):418–20. doi: 10.1210/jcem.82.2.3734
Cole TJ. Some questions about how growth standards are used. Horm Res (1996) 45(Suppl 2):18–23. doi: 10.1159/000184843
Tanner J. Use and abuse of growth standards. In: Falkner F Tanner JM, editors. Human growth, ed 2, vol. 3. New York: Plenum Press (1986). p. 95–109.
Coutant R Carel JC Letrait M Bouvattier C Chatelain P Coste J et al. Short stature associated with intrauterine growth retardation: final height of untreated and growth hormone-treated children. J Clin Endocrinol Metab (1998) 83(4):1070–4. doi: 10.1210/jcem.83.4.4750
Campos-Martorell A Fernández-Cancio M Clemente León M Mogas Viñals E Fàbregas Martori A Carrascosa Lezcano A et al. Seventy eight children born small for gestational age without catch-up growth treated with growth hormone from the prepubertal stage until adult height age. an evaluation of puberty and changes in the metabolic profile. Endocrinol Diabetes Y Nutrición (English ed) (2021) 68(9):612–20. doi: 10.1016/j.endien.2021.11.024
Zegher FD Albertsson-Wikland K Wollmann HA Chatelain P Chaussain JL et al. Growth Hormone Treatment of Short Children Born Small for Gestational Age: Growth Responses with Continuous and Discontinuous Regimens Over 6 Years. (2000) 85(8):6.
Maiorana A Cianfarani S. Impact of growth hormone therapy on adult height of children born small for gestational age. Pediatrics (2009) 124(3):e519–531. doi: 10.1542/peds.2009-0293
Patti G Malerba F Calevo MG Schiavone M Scaglione M Casalini E et al. Pubertal timing in children with silver Russell syndrome compared to those born small for gestational age. Front Endocrinol (Lausanne) (2022) 13:975511. doi: 10.3389/fendo.2022.975511
Binder G Schweizer R Blumenstock G Ferrand N. Adrenarche in silver-Russell syndrome: Timing and consequences. J Clin Endocrinol Metab (2017) 102(11):4100–8. doi: 10.1210/jc.2017-00874
Freire BL Homma TK Funari MFA Lerario AM Vasques GA Malaquias AC et al. Multigene sequencing analysis of children born small for gestational age with isolated short stature. J Clin Endocrinol Metab (2019) 104(6):2023–30. doi: 10.1210/jc.2018-01971
Homma TK Freire BL Honjo Kawahira RS Dauber A Funari MF de A Lerario AM et al. Genetic disorders in prenatal onset syndromic short stature identified by exome sequencing. J Pediatr (2019) 215:192–8. doi: 10.1016/j.jpeds.2019.08.024